Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 41.70B | 42.72B | 42.39B | 39.67B | 38.96B | 34.64B |
Gross Profit | 4.85B | 5.39B | 5.37B | 3.44B | 4.59B | 3.87B |
EBITDA | 2.69B | 4.25B | 3.38B | 919.29M | 4.76B | 4.21B |
Net Income | -712.97M | -206.54M | -593.46M | -2.66B | 208.22M | -225.05M |
Balance Sheet | ||||||
Total Assets | 51.01B | 47.84B | 50.20B | 49.20B | 51.05B | 49.75B |
Cash, Cash Equivalents and Short-Term Investments | 4.36B | 4.42B | 4.15B | 4.52B | 5.97B | 6.15B |
Total Debt | 20.00B | 18.26B | 18.06B | 17.44B | 16.32B | 17.10B |
Total Liabilities | 33.28B | 30.84B | 31.69B | 30.93B | 30.16B | 30.16B |
Stockholders Equity | 14.68B | 14.10B | 15.64B | 15.52B | 18.05B | 17.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.69B | -738.23M | -1.92B | 922.16M | -843.13M |
Operating Cash Flow | 0.00 | 814.56M | 4.74B | 1.83B | 4.19B | 3.25B |
Investing Cash Flow | 0.00 | -544.50M | -5.16B | -3.69B | -3.35B | -4.08B |
Financing Cash Flow | 0.00 | 8.82M | -155.21M | 305.18M | -1.36B | 2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥15.41B | 8.17 | 3.41% | -1.69% | 1.86% | ||
74 Outperform | ¥2.88B | 7.32 | 1.07% | 22.57% | 87.87% | ||
72 Outperform | ¥2.53B | 12.31 | 2.94% | 5.38% | ― | ||
72 Outperform | ¥3.71B | 4.58 | 5.36% | 1.36% | 48.32% | ||
64 Neutral | ¥18.82B | ― | 4.84% | 2.95% | 61.88% | ||
58 Neutral | ¥3.65B | ― | 2.41% | 0.78% | 63.89% | ||
58 Neutral | HK$14.15B | 4.41 | -3.01% | 7.30% | 3.67% | -54.16% |